{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:10:56Z","timestamp":1790795456615,"version":"4.1.0"},"reference-count":51,"publisher":"The Company of Biologists","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"am","delay-in-days":3059,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Tuberous sclerosis complex (TSC) is a multi-organ disorder caused by mutations of the TSC1 or TSC2 genes. A key function of these genes is to inhibit mTORC1 (mechanistic target of rapamycin complex 1) kinase signaling. Cells deficient for TSC1 or TSC2 have increased mTORC1 signaling and give rise to benign tumors, although, as a rule, true malignancies are rarely seen. In contrast, other disorders with increased mTOR signaling typically have overt malignancies. A better understanding of genetic mechanisms that govern the transformation of benign cells to malignant ones is crucial to understand cancer pathogenesis. We generated a zebrafish model of TSC and cancer progression by placing a heterozygous mutation of the tsc2 gene in a p53 mutant background. Unlike tsc2 heterozygous mutant zebrafish, which never exhibited cancers, compound tsc2;p53 mutants had malignant tumors in multiple organs. Tumorigenesis was enhanced compared with p53 mutant zebrafish. p53 mutants also had increased mTORC1 signaling that was further enhanced in tsc2;p53 compound mutants. We found increased expression of Hif1-\u03b1, Hif2-\u03b1 and Vegf-c in tsc2;p53 compound mutant zebrafish compared with p53 mutant zebrafish. Expression of these proteins probably underlies the increased angiogenesis seen in compound mutant zebrafish compared with p53 mutants and might further drive cancer progression. Treatment of p53 and compound mutant zebrafish with the mTORC1 inhibitor rapamycin caused rapid shrinkage of tumor size and decreased caliber of tumor-associated blood vessels. This is the first report using an animal model to show interactions between tsc2, mTORC1 and p53 during tumorigenesis. These results might explain why individuals with TSC rarely have malignant tumors, but also suggest that cancer arising in individuals without TSC might be influenced by the status of TSC1 and\/or TSC2 mutations and be potentially treatable with mTORC1 inhibitors.<\/jats:p>","DOI":"10.1242\/dmm.011494","type":"journal-article","created":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T02:35:25Z","timestamp":1364438125000},"source":"Crossref","is-referenced-by-count":11,"title":["Heterozygous inactivation of <i>tsc2<\/i> enhances tumorigenesis in <i>p53<\/i> mutant zebrafish"],"prefix":"10.1242","author":[{"given":"Seok-Hyung","family":"Kim","sequence":"first","affiliation":[{"name":"Vanderbilt University, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie L.","family":"Kowalski","sequence":"additional","affiliation":[{"name":"Vanderbilt University, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Carson","sequence":"additional","affiliation":[{"name":"Vanderbilt University, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Richard","family":"Bridges","sequence":"additional","affiliation":[{"name":"Vanderbilt University, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Ess","sequence":"additional","affiliation":[{"name":"Vanderbilt University, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","published-online":{"date-parts":[[2013,1,1]]},"reference":[{"key":"2021042501083969000_b1-0060925","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.1038\/sj.onc.1207721","article-title":"AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth","volume":"23","author":"Altomare","year":"2004","journal-title":"Oncogene"},{"key":"2021042501083969000_b2-0060925","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.0406252102","article-title":"tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors","volume":"102","author":"Berghmans","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2021042501083969000_b3-0060925","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0","article-title":"Mutations of the human PTEN gene","volume":"16","author":"Bonneau","year":"2000","journal-title":"Hum. Mutat."},{"key":"2021042501083969000_b4-0060925","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.molcel.2010.05.007","article-title":"Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply","volume":"38","author":"Choo","year":"2010","journal-title":"Mol. Cell"},{"key":"2021042501083969000_b5-0060925","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"2021042501083969000_b6-0060925","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1056\/NEJMc072500","article-title":"Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis","volume":"358","author":"Davies","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"2021042501083969000_b7-0060925","doi-asserted-by":"crossref","first-page":"9551","DOI":"10.1073\/pnas.1200019109","article-title":"Data-driven unbiased curation of the TP53 tumor suppressor gene mutation database and validation by ultradeep sequencing of human tumors","volume":"109","author":"Edlund","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2021042501083969000_b8-0060925","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1158\/1541-7786.MCR-07-2167","article-title":"Zebrafish as a cancer model","volume":"6","author":"Feitsma","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"2021042501083969000_b9-0060925","doi-asserted-by":"crossref","first-page":"8204","DOI":"10.1073\/pnas.0502857102","article-title":"The coordinate regulation of the p53 and mTOR pathways in cells","volume":"102","author":"Feng","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2021042501083969000_b10-0060925","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1158\/0008-5472.CAN-06-4149","article-title":"The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways","volume":"67","author":"Feng","year":"2007","journal-title":"Cancer Res."},{"key":"2021042501083969000_b11-0060925","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0092-8674(89)90045-7","article-title":"The p53 proto-oncogene can act as a suppressor of transformation","volume":"57","author":"Finlay","year":"1989","journal-title":"Cell"},{"key":"2021042501083969000_b12-0060925","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex","volume":"59","author":"Franz","year":"2006","journal-title":"Ann. Neurol."},{"key":"2021042501083969000_b13-0060925","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.bjc.6603492","article-title":"Mutations in BHD and TP53 genes, but not in HNF1beta gene, in a large series of sporadic chromophobe renal cell carcinoma","volume":"96","author":"Gad","year":"2007","journal-title":"Br. J. Cancer"},{"key":"2021042501083969000_b14-0060925","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1200\/JCO.2006.08.9821","article-title":"New waves of discovery: modeling cancer in zebrafish","volume":"25","author":"Goessling","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"2021042501083969000_b15-0060925","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1177\/1947601912445376","article-title":"Regulation of PI 3-K, PTEN, p53, and mTOR in malignant and benign tumors deficient in tuberin","volume":"2","author":"Habib","year":"2011","journal-title":"Genes Cancer"},{"key":"2021042501083969000_b16-0060925","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1083\/jcb.200403069","article-title":"The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins","volume":"166","author":"Harrington","year":"2004","journal-title":"J. Cell Biol."},{"key":"2021042501083969000_b17-0060925","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1593\/neo.04595","article-title":"mTOR promotes survival and astrocytic characteristics induced by Pten\/AKT signaling in glioblastoma","volume":"7","author":"Hu","year":"2005","journal-title":"Neoplasia"},{"key":"2021042501083969000_b18-0060925","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncb839","article-title":"TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling","volume":"4","author":"Inoki","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"2021042501083969000_b19-0060925","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1101\/gad.1110003","article-title":"Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling","volume":"17","author":"Inoki","year":"2003","journal-title":"Genes Dev."},{"key":"2021042501083969000_b20-0060925","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1494","article-title":"Dysregulation of the TSC-mTOR pathway in human disease","volume":"37","author":"Inoki","year":"2005","journal-title":"Nat. Genet."},{"key":"2021042501083969000_b21-0060925","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/ncb1183","article-title":"Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive","volume":"6","author":"Jacinto","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"2021042501083969000_b22-0060925","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1549-8719.2009.00012.x","article-title":"Rapamycin inhibits VEGF-induced microvascular hyperpermeability in vivo","volume":"17","author":"Kim","year":"2010","journal-title":"Microcirculation"},{"key":"2021042501083969000_b23-0060925","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1242\/dmm.005587","article-title":"Zebrafish model of tuberous sclerosis complex reveals cell-autonomous and non-cell-autonomous functions of mutant tuberin","volume":"4","author":"Kim","year":"2011","journal-title":"Dis. Model. Mech."},{"key":"2021042501083969000_b24-0060925","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1038\/emboj.2010.166","article-title":"S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response","volume":"29","author":"Lai","year":"2010","journal-title":"EMBO J."},{"key":"2021042501083969000_b25-0060925","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/dbio.2002.0711","article-title":"In vivo imaging of embryonic vascular development using transgenic zebrafish","volume":"248","author":"Lawson","year":"2002","journal-title":"Dev. Biol."},{"key":"2021042501083969000_b26-0060925","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1038\/sj.emboj.7601900","article-title":"Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53","volume":"26","author":"Lee","year":"2007","journal-title":"EMBO J."},{"key":"2021042501083969000_b27-0060925","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0022-5347(05)64608-3","article-title":"Renal cell carcinoma in a 2-year-old child with tuberous sclerosis","volume":"168","author":"Lendvay","year":"2002","journal-title":"J. Urol."},{"key":"2021042501083969000_b28-0060925","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","article-title":"p53, the cellular gatekeeper for growth and division","volume":"88","author":"Levine","year":"1997","journal-title":"Cell"},{"key":"2021042501083969000_b29-0060925","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1101\/gad.1363206","article-title":"Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways","volume":"20","author":"Levine","year":"2006","journal-title":"Genes Dev."},{"key":"2021042501083969000_b30-0060925","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00109-011-0735-5","article-title":"Metabolic regulation by p53","volume":"89","author":"Maddocks","year":"2011","journal-title":"J. Mol. Med. (Berl.)"},{"key":"2021042501083969000_b31-0060925","doi-asserted-by":"crossref","first-page":"27790","DOI":"10.1074\/jbc.M109.028860","article-title":"TSC2 deficiency increases PTEN via HIF1alpha","volume":"284","author":"Mahimainathan","year":"2009","journal-title":"J. Biol. Chem."},{"key":"2021042501083969000_b32-0060925","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","article-title":"Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/akt pathway","volume":"10","author":"Manning","year":"2002","journal-title":"Mol. Cell"},{"key":"2021042501083969000_b33-0060925","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1101\/gad.1314605","article-title":"Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2","volume":"19","author":"Manning","year":"2005","journal-title":"Genes Dev."},{"key":"2021042501083969000_b34-0060925","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1093\/hmg\/ddi225","article-title":"LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes","volume":"14","author":"Mehenni","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"2021042501083969000_b35-0060925","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1158\/1078-0432.CCR-09-0234","article-title":"The role of the Akt\/mTOR pathway in tobacco carcinogen-induced lung tumorigenesis","volume":"16","author":"Memmott","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"Suppl. 2","key":"2021042501083969000_b36-0060925","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1038\/onc.2009.352","article-title":"Common corruption of the mTOR signaling network in human tumors","volume":"27","author":"Menon","year":"2008","journal-title":"Oncogene"},{"key":"2021042501083969000_b37-0060925","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1242\/dmm.004747","article-title":"The zebrafish as a model for cancer","volume":"3","author":"Mione","year":"2010","journal-title":"Dis. Model. Mech."},{"key":"2021042501083969000_b38-0060925","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/cncr.24841","article-title":"p53 and MDM2 in renal cell carcinoma: biomarkers for disease progression and future therapeutic targets?","volume":"116","author":"Noon","year":"2010","journal-title":"Cancer"},{"key":"2021042501083969000_b39-0060925","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1242\/dmm.003749","article-title":"Genetic modeling of Li-Fraumeni syndrome in zebrafish","volume":"3","author":"Parant","year":"2010","journal-title":"Dis. Model. Mech."},{"key":"2021042501083969000_b40-0060925","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nrm2395","article-title":"Transcriptional control of human p53-regulated genes","volume":"9","author":"Riley","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2021042501083969000_b41-0060925","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"2021042501083969000_b42-0060925","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.cub.2004.08.026","article-title":"Inappropriate activation of the TSC\/Rheb\/mTOR\/S6K cassette induces IRS1\/2 depletion, insulin resistance, and cell survival deficiencies","volume":"14","author":"Shah","year":"2004","journal-title":"Curr. Biol."},{"key":"2021042501083969000_b43-0060925","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1097-2765(01)00323-9","article-title":"Regulation of PTEN transcription by p53","volume":"8","author":"Stambolic","year":"2001","journal-title":"Mol. Cell"},{"key":"2021042501083969000_b44-0060925","doi-asserted-by":"crossref","first-page":"13571","DOI":"10.1073\/pnas.202476899","article-title":"Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling","volume":"99","author":"Tee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2021042501083969000_b45-0060925","doi-asserted-by":"crossref","first-page":"34495","DOI":"10.1074\/jbc.C800170200","article-title":"Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2","volume":"283","author":"Toschi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"2021042501083969000_b46-0060925","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/nar\/gkm1040","article-title":"Algorithm for prediction of tumour suppressor p53 affinity for binding sites in DNA","volume":"36","author":"Veprintsev","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"2021042501083969000_b47-0060925","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35042675","article-title":"Surfing the p53 network","volume":"408","author":"Vogelstein","year":"2000","journal-title":"Nature"},{"key":"2021042501083969000_b48-0060925","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","article-title":"Blinded by the light: the growing complexity of p53","volume":"137","author":"Vousden","year":"2009","journal-title":"Cell"},{"key":"2021042501083969000_b49-0060925","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1172\/JCI200317222","article-title":"Loss of Tsc1\/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR","volume":"112","author":"Zhang","year":"2003","journal-title":"J. Clin. Invest."},{"key":"2021042501083969000_b50-0060925","doi-asserted-by":"crossref","first-page":"16940","DOI":"10.1073\/pnas.1011548107","article-title":"Highly aneuploid zebrafish malignant peripheral nerve sheath tumors have genetic alterations similar to human cancers","volume":"107","author":"Zhang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2021042501083969000_b51-0060925","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrd1606","article-title":"In vivo drug discovery in the zebrafish","volume":"4","author":"Zon","year":"2005","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Disease Models &amp; Mechanisms"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.biologists.com\/dmm\/article-pdf\/6\/4\/925\/1864911\/925.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.011494\/2035611\/dmm_011494.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.011494\/2035611\/dmm_011494.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T20:33:38Z","timestamp":1621370018000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/dmm\/article\/doi\/10.1242\/dmm.011494\/258844\/Heterozygous-inactivation-of-tsc2-enhances"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,1]]},"references-count":51,"URL":"https:\/\/doi.org\/10.1242\/dmm.011494","relation":{},"ISSN":["1754-8411","1754-8403"],"issn-type":[{"value":"1754-8411","type":"electronic"},{"value":"1754-8403","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1,1]]},"article-number":"dmm.011494"}}